Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Ann Marie Navar
Person

Ann Marie Navar

Tracked across 1 events · 24 articles · First seen Feb 04, 2026 · Last active Mar 23, 2026

Sentiment
50
Attention
6
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 50
Tech
Merck's Enlicitide Pill Reduces Cholesterol
Ann Marie Navar is the lead author of the study on enlicitide and a cardiologist at UT Southwestern Medical Center. Her research highlights the significant LDL cholesterol-lowering capabilities of enlicitide compared to other existing treatments.
Feb 04, 2026 · 24 articles
NEWSDESK
Track Ann Marie Navar live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.